618 related articles for article (PubMed ID: 31805875)
41. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
[TBL] [Abstract][Full Text] [Related]
42. Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease.
Kennedy NA; Jones GR; Plevris N; Patenden R; Arnott ID; Lees CW
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2269-2276.e4. PubMed ID: 30772585
[TBL] [Abstract][Full Text] [Related]
43. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
[TBL] [Abstract][Full Text] [Related]
44. Crohn's disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin.
Bickelhaupt S; Pazahr S; Chuck N; Blume I; Froehlich JM; Cattin R; Raible S; Bouquet H; Bill U; Rogler G; Frei P; Boss A; Patak MA
Neurogastroenterol Motil; 2013 Jun; 25(6):467-73. PubMed ID: 23495824
[TBL] [Abstract][Full Text] [Related]
45. Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease.
Penna FGC; Rosa RM; Pereira FH; Cunha PFS; Sousa SCS; Ferrari TCA; Cara C; Ferrari MLA
Gastroenterol Hepatol; 2021 Feb; 44(2):87-95. PubMed ID: 32680729
[TBL] [Abstract][Full Text] [Related]
46. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease.
Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W
Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756
[TBL] [Abstract][Full Text] [Related]
47. Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn's disease: a multicentre, prospective study.
Bruining DH; Oliva S; Fleisher MR; Fischer M; Fletcher JG;
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32499275
[TBL] [Abstract][Full Text] [Related]
48. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
[TBL] [Abstract][Full Text] [Related]
49. Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin.
Vázquez Morón JM; Pallarés Manrique H; Machancoses FH; Ramos Lora M; Ruiz Frutos C
Rev Esp Enferm Dig; 2017 Feb; 109(2):130-136. PubMed ID: 28071062
[TBL] [Abstract][Full Text] [Related]
50. Assessment of the response of patients with Crohn's disease to biological therapy using new non-invasive markers: lactoferrin and calprotectin.
Nogueira IM; Miszputen SJ; Ambrogini O; Artigiani-Neto R; Carvente CT; Zanon MI
Arq Gastroenterol; 2013 Apr; 50(2):130-7. PubMed ID: 23903623
[TBL] [Abstract][Full Text] [Related]
51. Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn's disease.
Primas C; Hopf G; Reinisch S; Baumann L; Novacek G; Reinisch W; Vogelsang H
Scand J Gastroenterol; 2021 Oct; 56(10):1169-1174. PubMed ID: 34314308
[TBL] [Abstract][Full Text] [Related]
52. Assessing pediatric ileocolonic Crohn's disease activity based on global MR enterography scores.
Pomerri F; Al Bunni F; Zuliani M; Guariso G; Gasparetto M; Giorgi B; Cananzi M; Muzzio PC
Eur Radiol; 2017 Mar; 27(3):1044-1051. PubMed ID: 27277259
[TBL] [Abstract][Full Text] [Related]
53. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
54. FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.
Saboury B; Salavati A; Brothers A; Basu S; Kwee TC; Lam MG; Hustinx R; Louis E; Torigian DA; Alavi A
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):605-14. PubMed ID: 24253895
[TBL] [Abstract][Full Text] [Related]
55. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
56. Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease.
Cozijnsen MA; Ben Shoham A; Kang B; Choe BH; Choe YH; Jongsma MME; Russell RK; Ruemmele FM; Escher JC; de Ridder L; Koletzko S; Martín-de-Carpi J; Hyams J; Walters T; Griffiths A; Turner D
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):133-140.e1. PubMed ID: 30981008
[TBL] [Abstract][Full Text] [Related]
57. [Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy].
García Sánchez Mdel V; González R; Iglesias Flores E; Gómez Camacho F; Casais Juanena L; Cerezo Ruiz A; Montero Pérez-Barquero M; Muntané J; de Dios Vega JF
Med Clin (Barc); 2006 Jun; 127(2):41-6. PubMed ID: 16801001
[TBL] [Abstract][Full Text] [Related]
58. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
59. Comparison of Magnetic Resonance Enterography Global Score (MEGS) with indices of Crohn's disease activity in South Asian population.
Jose SK; Simon B; Simon EG; Eapen A; John RA; Putta T; Dutta AK; Pulimood AB
Abdom Radiol (NY); 2022 Feb; 47(2):547-553. PubMed ID: 34958408
[TBL] [Abstract][Full Text] [Related]
60. Heat shock protein 90 and inflammatory activity in newly onset Crohn's disease.
Grimstad T; Kvivik I; Kvaløy JT; Aabakken L; Omdal R
Scand J Gastroenterol; 2018 Dec; 53(12):1453-1458. PubMed ID: 30625276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
